Huntsman Cancer Institute (HCI) is a leader in the study of cancer genetics and its researchers have discovered more inherited cancer genes than any other cancer center in the world. Genes responsible for breast and ovarian cancer, colon cancer, head and neck cancer, and melanoma were identified here.

From its beginning, HCI has followed a “lab bench to patient bedside” research model. HCI is the only cancer center in the region that conducts basic, translational, and clinical research simultaneously, taking what’s learned in the laboratory through drug development and into the clinic.

Recent News

Press Releases, In The Media

Huntsman Cancer Institute Research Holds Promise for Personalized Lung Cancer Treatments

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified a targeted drug combination that worked well with one specific tumor type. The study was published today in Cancer Cell. The findings suggest small cell lung cancer should not be treated as a uniform disease

Read More

Press Releases, In The Media

Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations

Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).

Read More

Press Releases, In The Media

Huntsman Cancer Institute Leads International Colorectal Study

Huntsman Cancer Institute (HCI) at the University of Utah will head an international study to find out how lifestyle and other health factors impact colon and rectal cancer outcomes. HCI was awarded an $8.8 million grant from the National Institutes of Health to lead and expand an ongoing project in colon cancer research.

Read More

Health Care Public Affairs

Voices in Precision Medicine: Speaking on the Law, Ethics, and Science

Precision medicine promises health care tailored to every individual, a mission that opens exciting possibilities and poses unique challenges. How do we control cost, equalize access to care, and speed the journey to success? On Dec 1 and 2, 2016, scientists, doctors, lawyers, and ethicists from across the country met to discuss these topics, and more.

Read More